Dr. Darren Yuen still remembers the young woman who came to St. Michael’s Hospital in 2017 with working kidneys. He needed to find out whether they were scarred, and that meant performing a kidney biopsy.
But biopsies have limitations. They remove and examine only a small portion of the kidney, potentially missing scarring elsewhere in the organ. They’re also invasive, painful, and carry the risk of serious complications.
For Dr. Yuen’s patient, that risk became a devastating reality. The procedure caused a bleed that led to kidney failure, leaving the young woman in need of a kidney transplant.
“Because of something I ordered, she needed a transplant to live,” says Dr. Yuen, a nephrologist and scientist at St. Michael’s. “And I felt very responsible for that.”
He had always understood the risks of a kidney biopsy, but until he watched one change a young patient’s life, those risks had been minor and abstract.
“From that day, I vowed that I would find a better way,” Dr. Yuen says.
A different approach
Dr. Yuen got to work. He brought the challenge to Dr. Michael Kolios, an expert in biomedical physics who believed imaging might offer a safer approach.
Their conversation caught the attention of Dr. Eno Hysi, then a graduate student working with Dr. Kolios. He was not looking for new research. Kidney disease was outside his field. And his PhD work in cancer treatment monitoring was already well underway.
“I couldn’t stop thinking about the problem,” Dr. Hysi says. “And I couldn’t accept that the current standard was the best we could do for people.”
Determined to do better, he put his PhD research on hold to find a new way to image kidney scarring.
“Darren knows how scarring damages the kidney,” Dr. Hysi says. “But I know how to image damaged organs. It’s a perfect combination of skills.”
Drs. Yuen and Hysi began using photoacoustic imaging, which turns laser light into ultrasound waves. They first tested whether collagen, a protein found in scars, produced a different ultrasound signal than healthy kidney tissue.
After testing the technology in preclinical models, they moved on to portions of kidneys removed during cancer surgery at St. Mike’s. Eventually, they began imaging donor kidneys before transplantation.
Transplant kidneys often arrived in the middle of the night. When one reached St. Mike’s at 2 a.m., Dr. Hysi rushed in to image it before surgery. There was no second chance to collect the data. If the kidney was there, so was Dr. Hysi.
“It changed the way I looked at research,” Dr. Hysi, The Nicole and Thor Eaton-Canada Research Chair in Quantitative Ultrasound and Photoacoustic Imaging, says. “This was someone’s kidney. Someone who might have waited many, many years for a transplant. The schedule was grueling. But I knew what was at stake. I had a responsibility to make every measurement count.”
What they saw in their imaging matched what pathologists found in tissue samples. For the first time, Dr. Yuen and Dr. Hysi realized that detecting kidney scarring without relying on a biopsy could become real.
“And that was when our laser broke,” Dr. Hysi says.
A forced change
The specialized laser required maintenance by a technician based in the U.S., and when COVID-19 hit, border restrictions meant he could no longer travel to Toronto.
“It was heartbreaking,” Dr. Yuen recalls. But Dr. Hysi was not ready to stop. Rather than wait for the laser to be repaired, he wondered whether they needed one at all.
He explains his theory with a simple analogy: “Think about tapping on a hollow wall versus a solid one. They sound different because what is inside them is different. Those differences in sound create distinct signals.”
The same principle applies to the kidney. Scarred tissue should produce a different ultrasound signal than healthy tissue, he says. And conventional ultrasound machines were already capturing those signals every day. He was convinced the answer was already hiding in the ultrasound data. But how could he measure it?
Dr. Hysi dove into decades of existing research, chasing every clue about how sound waves interact with tissue. He then used what he learned to identify the hidden signals that distinguish scarred kidney tissue from healthy tissue.
The result was ScarScan, the world’s first software algorithm that could analyze conventional ultrasounds for signs of kidney scarring without a laser.
The Spark of Angels Den
By 2024, Drs. Yuen and Hysi had spent years developing ScarScan. That year, they brought it to Angels Den, Canada’s largest medical research competition, where they won the Keenan Award for Medical Discovery. The duo then decided to commercialize the technology into a startup company, ScarDX.
The competition connected them with supporters and advisors who helped guide its commercialization. Unity Health Toronto’s commercialization team also helped them file a patent.
“Without Angels Den, none of this would be possible,” Dr. Yuen says.
In October 2026, ScarDX officially launched. The software is being tested at St. Mike’s, across Canada, and in the U.S. as Dr. Yuen and Dr. Hysi work toward regulatory approval. It’s an exciting milestone, but for the doctors, what matters most is bringing ScarDX to patients.
“The patients I care for are the ones taking part in our studies,” Dr. Yuen says. “They’re asking me, ‘How is it going? Is it helping?’ And I can finally tell them that we’re getting closer.”
Donate to St. Michael's Hospital Foundation.